These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 1691400)
1. The emerging role of ACE inhibitors in the treatment of cardiovascular disease. Zannad F J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S1-5. PubMed ID: 1691400 [TBL] [Abstract][Full Text] [Related]
2. New angiotensin converting enzyme inhibitors. Their role in the management of hypertension. Laragh JH Am J Hypertens; 1990 Nov; 3(11):257S-265S. PubMed ID: 2261144 [TBL] [Abstract][Full Text] [Related]
5. Relationship between decrease in afterload and beneficial effects of ACE inhibitors in experimental cardiac hypertrophy and congestive heart failure. Michel JB Eur Heart J; 1990 May; 11 Suppl D():17-26. PubMed ID: 2141818 [TBL] [Abstract][Full Text] [Related]
6. Evidence-based medicine and ACE inhibition. Borghi C; Ambrosioni E J Cardiovasc Pharmacol; 1998; 32 Suppl 2():S24-35. PubMed ID: 9736438 [TBL] [Abstract][Full Text] [Related]
7. Improvement of cardiac function by angiotensin converting enzyme inhibition. Sites of action. Dietz R; Waas W; Süsselbeck T; Willenbrock R; Osterziel KJ Circulation; 1993 May; 87(5 Suppl):IV108-16. PubMed ID: 8485825 [TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme inhibitors in the clinical setting of chronic congestive heart failure. Reyes AJ Am J Cardiol; 1995 Jun; 75(18):50F-55F. PubMed ID: 7778535 [TBL] [Abstract][Full Text] [Related]
9. Use of ACE inhibitors in the treatment of cardiovascular disease. Gums JG Am Pharm; 1992 Jun; NS32(6):62-70. PubMed ID: 1615843 [TBL] [Abstract][Full Text] [Related]
10. Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders. Plosker GL; Sorkin EM Drugs; 1994 Aug; 48(2):227-52. PubMed ID: 7527326 [TBL] [Abstract][Full Text] [Related]
11. Does aspirin interfere with the therapeutic efficacy of angiotensin-converting enzyme inhibitors in hypertension or congestive heart failure? Nawarskas JJ; Spinler SA Pharmacotherapy; 1998; 18(5):1041-52. PubMed ID: 9758314 [TBL] [Abstract][Full Text] [Related]
12. Patterns of physician use of angiotensin converting enzyme inhibitors in the inpatient treatment of congestive heart failure. Ghali JK; Giles T; Gonzales M; Horswell R; Kumar S; Lejuene A; Livaudais GF; Sarkar IC J La State Med Soc; 1997 Dec; 149(12):474-84. PubMed ID: 9425858 [TBL] [Abstract][Full Text] [Related]
16. Underutilisation of ACE inhibitors in patients with congestive heart failure. Bungard TJ; McAlister FA; Johnson JA; Tsuyuki RT Drugs; 2001; 61(14):2021-33. PubMed ID: 11735631 [TBL] [Abstract][Full Text] [Related]
17. Temporal patterns in the medical treatment of congestive heart failure with angiotensin-converting enzyme inhibitors in older adults, 1989 through 1995. Smith NL; Psaty BM; Pitt B; Garg R; Gottdiener JS; Heckbert SR Arch Intern Med; 1998 May; 158(10):1074-80. PubMed ID: 9605778 [TBL] [Abstract][Full Text] [Related]
18. Role of angiotensin-converting-enzyme inhibitors in the treatment of hypertension. Hilleman DE Am J Health Syst Pharm; 2000 Oct; 57 Suppl 1():S8-11. PubMed ID: 11030017 [TBL] [Abstract][Full Text] [Related]
19. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension. Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154 [TBL] [Abstract][Full Text] [Related]
20. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option. Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]